eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | herpes simplex |
| Comorbidity | C0007113|rectal cancer |
| Sentences | 1 |
| PubMedID- 20486770 | This multicenter phase i/ii study evaluated the safety, pharmacokinetics, and antitumor effects of repeated doses of nv1020, a genetically engineered oncolytic herpes simplex virus, in patients with advanced metastatic colorectal cancer (mcrc). |
Page: 1